An Interview with Antonio Francesco Di Naro for the C Suite Feature of Sanità33, by Ludovico Baldessin From pioneering ...
ReChb: An Ancestral CRISPR–Cas12a variant with flexible applications
Ancestral sequence reconstruction has led to the discovery and synthesis of ReChb, a revolutionary variant of CRISPR–C...
Gut Revolution: Fecal Transplants vs. Live Biotherapeutic Products
An article published in Gut Microbes (2024) introduces a groundbreaking class of drugs known as Live Biotherapeutic Prod...
Biotech: Angelini Ventures Leads €20 Million Financing Round for NeumirnaNeumirna Therapeutics: Pioneering RNA-Based Therapies for Neurological Disorders
Neumirna Therapeutics, a Danish biotechnology company specializing in RNA-based therapies for next-generation treatments...
Liquid Biopsy: ENEA Tech Invests €15 Million in Tethis to Revolutionize Cancer Diagnostics
An Italian innovation promising early diagnosis, less invasive procedures, and personalized care for oncology patients. ...
ENEA-Tech and Biomedical Foundation: Investment in Innovative Radiotherapy Project for the Treatment of Inoperable Solid Tumors
The ENEA-Tech and Biomedical Foundation has announced a significant strategic investment of €6 million in BetaGlue The...